Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support

Heart and Vessels

Volumn 28, Issue 1, 2013, Pages 86-90

  Ishida, Kohki ^a   Wada, Hiroshi ^a   Sakakura, Kenichi ^a   Kubo, Norifumi ^a   Ikeda, Nahoko ^a   Sugawara, Yoshitaka ^a   Ako, Junya ^a   Momomura, Shin Ichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac function; Fulminant myocarditis; Long term prognosis; Percutaneous extracorporeal cardiopulmonary support

Indexed keywords

DOBUTAMINE; DOPAMINE; NORADRENALIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONVALESCENCE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; EXTRACORPOREAL CIRCULATION; FATALITY; FEMALE; FULMINANT MYOCARDITIS; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART SIZE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MALE; MYOCARDITIS; PERCUTANEOUS EXTRACORPOREAL CARDIOPULMONARY SUPPORT; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RECURRENT DISEASE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84872610437     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-011-0211-8     Document Type: Article

References (18)

1. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL (1991) Clinicopathologic description of myocarditis. J Am Coll Cardiol 18(7):1617-1626
2. Cooper LT Jr (2009) Myocarditis. N Engl J Med 360(15):1526-1538
3. Acker MA (2001) Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg 71(3 Suppl):S73-76 (discussion S82-85)
4. Maejima Y, Yasu T, Kubo N, Kawahito K, Omura N, Katsuki T, Tsukamoto Y, Sugawara Y, Hashimoto S, Tsuruya Y, Hirahara T, Takagi Y, Kobayashi N, Funayama H, Ikeda N, Ishida T, Fujii M, Ino T, Saito M (2004) Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device. Circ J 68(9):829-833
5. Chen YS, Yu HY (2005) Choice of mechanical support for fulminant myocarditis: ECMO vs. VAD? Eur J Cardiothorac Surg 27(5):931-932 (author reply 932)
6. Unosawa S, Hata M, Sezai A, Niino T, Yoshitake I, Shimura K, Takamori T, Minami K (2010) Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case. Ann Thorac Cardiovasc Surg 16(1):48-51
7. Yasu T, Murata S, Katsuki T, Fujii M, Kubo N, Ohmura N, Ino T, Saito M (1997) Acutely severe myocarditis successfully treated by percutaneous cardiopulmonary support applied by a newly developed heparin-binding oxygenator and circuits. Jpn Circ J 61(12):1037-1042
8. Kawahito K, Murata S, Yasu T, Adachi H, Ino T, Saito M, Misawa Y, Fuse K, Shimada K (1998) Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse. Am J Cardiol 82(7):910-911
9. Aoyama N, Izumi T, Hiramori K, Isobe M, Kawana M, Hiroe M, Hishida H, Kitaura Y, Imaizumi T (2002) National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 66(2):133-144
10. Hare JM, Baughman KL (2001) Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification. Eur Heart J 22(4):269-270
11. Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C (2006) Outcome of acute fulminant myocarditis in children. Heart 92(9):1269-1273
12. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36(1):227-232
13. Asaumi Y, Yasuda S, Morii I, Kakuchi H, Otsuka Y, Kawamura A, Sasako Y, Nakatani T, Nonogi H, Miyazaki S (2005) Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J 26(20):2185-2192
14. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342(10):690-695
15. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28(11):1326-1333
16. Wang Y, Shimada M, Xu Y, Hu D, Nishio R, Matsumori A (2010) Role of substance P in viral myocarditis in mice. Heart Vessels 25(4):348-352
17. Kamal FA, Watanabe K, Ma M, Abe Y, Elbarbary R, Kodama M, Aizawa Y (2011) A novel phenylpyridazinone, T-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy. Heart Vessels 26(1):81-90
18. Lee CH, Tsai WC, Hsu CH, Liu PY, Lin LJ, Chen JH (2006) Predictive factors of a fulminant course in acute myocarditis. Int J Cardiol 109(1):142-145